BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10098887)

  • 1. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme.
    Blázquez C; Sánchez C; Daza A; Galve-Roperh I; Guzmán M
    J Neurochem; 1999 Apr; 72(4):1759-68. PubMed ID: 10098887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes.
    Sánchez C; Galve-Roperh I; Rueda D; Guzmán M
    Mol Pharmacol; 1998 Nov; 54(5):834-43. PubMed ID: 9804618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of carnitine palmitoyltransferase I in the control of ketogenesis in primary cultures of rat astrocytes.
    Blázquez C; Sánchez C; Velasco G; Guzmán M
    J Neurochem; 1998 Oct; 71(4):1597-606. PubMed ID: 9751193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.
    Sánchez C; Galve-Roperh I; Canova C; Brachet P; Guzmán M
    FEBS Lett; 1998 Sep; 436(1):6-10. PubMed ID: 9771884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan.
    Sánchez C; Rueda D; Ségui B; Galve-Roperh I; Levade T; Guzmán M
    Mol Pharmacol; 2001 May; 59(5):955-9. PubMed ID: 11306675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AMP-activated protein kinase is involved in the regulation of ketone body production by astrocytes.
    Blázquez C; Woods A; de Ceballos ML; Carling D; Guzmán M
    J Neurochem; 1999 Oct; 73(4):1674-82. PubMed ID: 10501215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses. Evidence for a decreased sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition after glucagon or cyclic AMP treatment.
    Pégorier JP; Garcia-Garcia MV; Prip-Buus C; Duée PH; Kohl C; Girard J
    Biochem J; 1989 Nov; 264(1):93-100. PubMed ID: 2557835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of flux control exerted by mitochondrial outer-membrane carnitine palmitoyltransferase over ketogenesis in hepatocytes and mitochondria isolated from suckling or adult rats.
    New KJ; Krauss S; Elliott KR; Quant PA
    Eur J Biochem; 1999 Feb; 259(3):684-91. PubMed ID: 10092853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic stimulation of mouse spleen lymphocytes by low doses of delta9-tetrahydrocannabinol.
    Sánchez C; Velasco G; Guzmán M
    Life Sci; 1997; 60(19):1709-17. PubMed ID: 9129126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.
    Gómez del Pulgar T; Velasco G; Guzmán M
    Biochem J; 2000 Apr; 347(Pt 2):369-73. PubMed ID: 10749665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the lack of involvement of sphingomyelin hydrolysis in the tumor necrosis factor-induced secretion of nerve growth factor in primary astrocyte cultures.
    Galve-Roperh I; Sánchez C; Ségui B; Haro A; Díaz-Laviada I; Levade T
    J Neurochem; 1998 Aug; 71(2):498-505. PubMed ID: 9681439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malonyl-CoA-independent acute control of hepatic carnitine palmitoyltransferase I activity. Role of Ca2+/calmodulin-dependent protein kinase II and cytoskeletal components.
    Velasco G; Geelen MJ; Gómez del Pulgar T; Guzmán M
    J Biol Chem; 1998 Aug; 273(34):21497-504. PubMed ID: 9705278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
    Shivachar AC; Martin BR; Ellis EF
    Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
    Bouaboula M; Poinot-Chazel C; Bourrié B; Canat X; Calandra B; Rinaldi-Carmona M; Le Fur G; Casellas P
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):637-41. PubMed ID: 8526880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
    Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.
    French ED
    Neurosci Lett; 1997 May; 226(3):159-62. PubMed ID: 9175591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase.
    Rueda D; Galve-Roperh I; Haro A; Guzmán M
    Mol Pharmacol; 2000 Oct; 58(4):814-20. PubMed ID: 10999952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line.
    Upham BL; Rummel AM; Carbone JM; Trosko JE; Ouyang Y; Crawford RB; Kaminski NE
    Int J Cancer; 2003 Mar; 104(1):12-8. PubMed ID: 12532414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism.
    Ramer R; Brune K; Pahl A; Hinz B
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1144-52. PubMed ID: 11527419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
    Velasco G; Geelen MJ; Guzmán M
    Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.